
Anish Bhatnagar MD
Critical Care Medicine
Pulmonary and Critical Care Medicine Fellow
Join to view full profile
90 Bergen St# 4500Newark, NJ 07103
Phone+1 973-972-2500
Dr. Bhatnagar is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mass General Brigham/Brigham and Women's HospitalFellowship, Pulmonary Disease and Critical Care Medicine, 2022 - 2025
Beth Israel Deaconess Medical CenterChief Residency, Internal Medicine, 2021 - 2022
Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 2018 - 2021
University of Utah School of MedicineClass of 2018
Certifications & Licensure
MA State Medical License 2018 - 2027
NJ State Medical License 2025 - 2027
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Critical Care Medicine
American Board of Internal Medicine Pulmonary Disease
Publications & Presentations
PubMed
- 13 citationsDiazoxide choline extended-release tablet in people with Prader-Willi syndrome: results from long-term open-label study.Jennifer L Miller, Evelien Gevers, Nicola Bridges, Jack A Yanovski, Parisa Salehi
Obesity. 2024-02-01 - 33 citationsDiazoxide Choline Extended-Release Tablet in People With Prader-Willi Syndrome: A Double-Blind, Placebo-Controlled Trial.Jennifer L Miller, Evelien Gevers, Nicola Bridges, Jack A Yanovski, Parisa Salehi
The Journal of Clinical Endocrinology and Metabolism. 2023-06-16 - A Veteran Presenting for Low Testosterone and Lower Urinary Tract Symptoms.Anish Bhatnagar, Sonia Ananthakrishan, Ian Rifkin, Anthony C Breu
Federal Practitioner. 2022-10-01
Press Mentions
Vykat XR Approved as First Treatment for Excessive Appetite in Prader-Willi SyndromeApril 15th, 2025
First Drug Approved for Hyperphagia in Prader-Willi SyndromeMarch 28th, 2025
Diazoxide Choline Gets Priority Review for Prader-Willi SyndromeAugust 27th, 2024
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









